The following links are provided by IPC for the benefit of its users and members. IPC does not attest to the accuracy of or assume any responsibility for the content or information provided by linked sites, nor does it endorse or recommend any specific content or information contained therein. Please be aware that when you exit the IPC website you are subject to the policies and procedures of the new site.
North American
In the latest Psoriasis Review IPC's bi-annual review of the latest news in the field of psoriasis. read the latest issue
Psoriasis News Announcing IPC's Newest Corporate Partner: Ortho Dermatologics9/3/2019 11:11:00 AM Get Connected: World Psoriasis Day 20199/3/2019 9:41:00 AM In Memory of Gladys León Dorantes9/2/2019 3:24:00 PM Re-Categorization of Psoriasis Severity: Delphi Consensus from the International Psoriasis Council8/29/2019 7:13:00 AMPsoriasis severity categories have been important tools for clinicians to use in treatment decisions as well as to determine eligibility criteria for clinical studies. However, due to the heterogeneity of severity classifications and their lack of consideration for the impact of psoriasis involvement of special areas or past treatment history, patients may be mis-categorized, which can lead to under-treatment of psoriasis. More News